We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGII icon
1726
Digi International
DGII
$3.17B
$478K 0.01%
30,595
+25,076
+454% +$329K
GERN icon
1727
Geron
GERN
$1.05B
$478K 0.01%
274,305
+234,624
+591% +$434K
TG icon
1728
Tredegar Corp
TG
$275M
$477K 0.01%
32,103
+25,367
+377% +$416K
AVD icon
1729
American Vanguard Corp
AVD
$64.6M
$476K 0.01%
36,199
+28,488
+369% +$397K
SITM icon
1730
SiTime
SITM
$20.1B
$476K 0.01%
5,670
+4,552
+407% +$284K
ULTA icon
1731
Ulta Beauty
ULTA
$23.3B
$476K 0.01%
2,124
+707
+50% +$152K
ECOM
1732
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$476K 0.01%
32,895
+22,273
+210% +$370K
ANGO icon
1733
AngioDynamics
ANGO
$651M
$475K 0.01%
39,331
+32,197
+451% +$306K
JBSS icon
1734
John B. Sanfilippo & Son
JBSS
$978M
$474K 0.01%
6,291
+5,444
+643% +$454K
BMRN icon
1735
BioMarin Pharmaceuticals
BMRN
$13.5B
$473K 0.01%
6,220
+3,719
+149% +$376K
IYE icon
1736
iShares US Energy ETF
IYE
$1.79B
$473K 0.01%
29,616
-17,011
-36% -$321K
OBK icon
1737
Origin Bancorp
OBK
$1.66B
$473K 0.01%
22,149
+18,080
+444% +$405K
CPF icon
1738
Central Pacific Financial
CPF
$996M
$472K 0.01%
34,769
+19,207
+123% +$291K
SLT
1739
DELISTED
Pacer Salt High truBeta US Market ETF
SLT
$472K 0.01%
16,302
-13,373
-45% -$363K
NDAQ icon
1740
Nasdaq
NDAQ
$53.1B
$471K 0.01%
11,505
+4,872
+73% +$208K
PDFS icon
1741
PDF Solutions
PDFS
$2.08B
$471K 0.01%
25,158
+22,256
+767% +$458K
SRDX
1742
DELISTED
Surmodics
SRDX
$471K 0.01%
12,094
+9,457
+359% +$415K
CNXN icon
1743
PC Connection
CNXN
$2.04B
$469K 0.01%
11,433
+9,229
+419% +$404K
LABD icon
1744
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.3M
$469K 0.01%
785
-2,096
-73% -$1.35M
HBNC icon
1745
Horizon Bancorp
HBNC
$1.05B
$468K 0.01%
46,359
+39,332
+560% +$408K
KEY icon
1746
KeyCorp
KEY
$24.3B
$468K 0.01%
39,212
-81,236
-67% -$990K
KMI icon
1747
Kinder Morgan
KMI
$70.1B
$468K 0.01%
37,928
-9,600
-20% -$134K
EBSB
1748
DELISTED
Meridian Bancorp, Inc.
EBSB
$468K 0.01%
45,226
+38,615
+584% +$438K
ASIX icon
1749
AdvanSix
ASIX
$452M
$467K 0.01%
36,263
+27,670
+322% +$345K
ODFL icon
1750
Old Dominion Freight Line
ODFL
$43.4B
$466K 0.01%
5,154
+3,418
+197% +$321K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.